Heron Therapeutics (HRTX) EPS (Basic) (2011 - 2026)
Heron Therapeutics' (HRTX) quarterly EPS (Basic) came in at -$0.01 in Q2 2026, down 0.92% on a YoY basis from -$0.01 in Q2 2025, and up 57.35% quarter-over-quarter from -$0.03 in Q1 2026.
Powered by 
Analysis
Heron Therapeutics (HRTX) EPS (Basic) (2011 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has reported EPS (Basic) for 16 consecutive years, with -$0.01 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) fell 0.92% year-over-year to -$0.01; the trailing twelve-month figure through Jun 2026 stood at -$0.05 (down 250.59% YoY), and the FY2025 full-year result was -$0.06, up 33.45% from the prior year.
- EPS (Basic) grew to -$0.01 in Q2 2026 per HRTX's latest filing, from -$0.03 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.05 in Q4 2024 and bottomed at -$0.62 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.14 across 5 years, with a median of -$0.04 in 2024.
- The sharpest annual moves came in 2024 and 2026: EPS (Basic) surged 201.45% in 2024, then plunged 223.0% in 2026.
- Over 5 years, EPS (Basic) stood at -$0.17 in 2022, then jumped by 70.97% to -$0.05 in 2023, then soared by 201.45% to $0.05 in 2024, then slumped by 76.25% to $0.01 in 2025, then slumped by 189.56% to -$0.01 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.01, -$0.03, and $0.01 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -0.40 |
| 10 | Heron Therapeutics | 63.12 Mn | 20.45 Mn | 26.09 Mn | -0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01 |
| Mar 31, 2026 | -0.03 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | -0.02 |
| Jun 30, 2025 | -0.01 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | -0.03 |
| Jun 30, 2024 | -0.04 |
| Mar 31, 2024 | -0.03 |
| Dec 31, 2023 | -0.05 |
| Sep 30, 2023 | -0.17 |
| Jun 30, 2023 | -0.35 |
| Mar 31, 2023 | -0.28 |
| Dec 31, 2022 | -0.17 |
| Sep 30, 2022 | -0.38 |
| Jun 30, 2022 | -0.48 |
| Mar 31, 2022 | -0.62 |
| Dec 31, 2021 | -0.54 |
| Sep 30, 2021 | -0.51 |